Rocky mountain spotted fever

Rickettsial Diseases

Volumn , Issue , 2007, Pages 97-116

  Childs, James E ^a   Paddock, Christopher D ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84877912363     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (149)

1. McCullough GT. Spotted fever. Med Sentinel 1902; 10:225-228.
2. Ormsbee RA. A review: “Studies in Pyroplasmosis hominis (‘spotted fever’ or ‘tick fever’ of the Rocky Mountains)" by Louis B. Wison and William M. Chow. Rev Infect Dis 1979; 1:559-562.
3. Rucker WC. Rocky Mountain spotted fever. Public Health Rep 1912; 27:1465-1482.
4. Wood MW. Spotted fever as reported from Idaho. Rep Surgeon General US Army, 1896.
5. Maxey EE. Some observations on the so-called spotted fever of Idaho. Med Sentinel 1899; 7:433-438.
6. Wilson LB, Chowning WM. Studies in Pyroplasmosis hominis (“spotted fever” or “tick fever” of the Rocky Mountains). J Infect Dis 1904; 1:31-57.
7. Heyneman D. The blight of the Bitterroot, the mysterious Rocky Mountain spotted fever, and the significant role of Wilson and Chowning-a commentary. Wilderness Environ Med 2001; 12:118-120.
8. Ricketts HT. A summary of investigations of the nature and means of transmission of Rocky Mountain spotted fever. Contributions to Medical Science by Howard Taylor Ricketts, 1870-1910. Chicago: University of Chicago Press, 1911:278-372.
9. Philip RN. Rocky Mountain Spotted Fever in Western Montana. Hamilton, Montana: The Bitter Root Historical Society, 2000.
10. LaBier CR. Rocky Mountain spotted fever in Indiana. J Indiana Med Assoc 1925; 18:418-419.
11. Parker RR. Certain phases of the problem of Rocky Mountain spotted fever: a summary. Arch Pathol 1933; 15:398-429.
12. Badger LF, Dyer RE, Rumreich A. An infection of the Rocky Mountain type: identification in the eastern part of the United States. Public Health Rep 1931; 46:463-470.
13. Rumreich A, Dyer RE, Badger LF. The typhus-Rocky Mountain spotted fever group: an epidemiological and clinical study in the eastern and southeastern states. Public Health Rep 1931; 46:470-480.
14. Dumler JS. Fatal Rocky Mountain spotted fever in Maryland-1901. J Am Med Assoc 1991; 265:718.
15. Piza J, Salles-Gomes L, Meyer J, et al. Le typhus exanthematique a São Paulo. C R Seances Soc Biol Fil 1931; 106:1020-1022.
16. Parker RR, Davis GE. Protective value of convalescent sera of São Paulo exanthematic typhus against the virus of Rocky Mountain spotted fever. Public Health Rep 1933; 48:501-507.
17. Emelyanov VV. Evolutionary relationship of rickettsiae and mitochondria. FEBS Lett 2001; 501:11-18.
18. Eremeeva ME, Madan A, Shaw CD, et al. New perspectives on rickettsial evolution from new genome sequences of Rickettsia, particularly R. canadensis, and Orientia tsutsugamushi. Ann NY Acad Sci 2005; 1063:47-63.
19. Andersson JO, Andersson SG. Pseudogenes, junk DNA, and the dynamics of Rickettsia genomes. Mol Biol Evol 2001; 18:829-839.
20. Ogata H, Audic S, Renesto-Audiffren P, et al. Mechanisms of evolution in Rickettsia conorii and R. prowazekii. Science 2001; 293:2093-2098.
21. Burgdorfer W. Ecological and epidemiological considerations of Rocky Mountain spotted fever and scrub typhus. In: Walker DH, ed. Biology of Rickettsial Disease. Boca Raton, FL: CRC Press, 1988:34-50.
22. Demma LJ, Traeger MS, Nicholson WL, et al. Rocky Mountain spotted fever from an unexpected tick vector in Arizona. N Engl J Med 2005; 353:587-594.
23. Guedes E, Leite RC, Prata MC, et al. Detection of Rickettsia rickettsii in the tick Amblyomma cajennense in a new Brazilian spotted fever-endemic area in the state of Minas Gerais. Mem Inst Oswaldo Cruz 2005; 100:841-845.
24. Sonenshine DE. The Biology of Ticks. Oxford: Oxford University Press, 1993.
25. Burgdorfer W, Brinton LP. Mechanisms of transovarial infection of spotted fever rickettsiae in ticks. Ann NY Acad Sci 1975; 266:61-72.
26. Burgdorfer W. Vertical transmission of spotted fever group and scrub typhus rickettsiae. Curr Top Vector Res 1984; 2:77-92.
27. Niebylski ML, Peacock MG, Schwan TG. Lethal effect of Rickettsia rickettsii on its tick vector (Dermacentor andersoni). Appl Environ Microbiol 1999; 65:773-778.
28. Burgdorfer W. A review of Rocky Mountain spotted fever (tick-borne typhus), its agent, and its tick vectors in the United States. J Med Entomol 1975; 12:269-278.
29. Badger LF. Rocky Mountain spotted fever: susceptibility of the dog and sheep to the virus. Public Health Rep 1933; 48:795.
30. Price WH. The epidemiology of Rocky Mountain spotted fever. II. Studies on the biological survival mechanism of Rickettsia rickettsii. Am J Hyg 1954; 60:292-319.
31. McDade JE, Newhouse VF. Natural history of Rickettsia rickettsii. Annu Rev Microbiol 1986; 40:287-309.
32. Schriefer ME, Azad AF. Changing ecology of Rocky Mountain spotted fever. In: Sonenshine DE, Mather TN, eds. Ecological Dynamics of Tick-borne Zoonoses. New York: Oxford University Press, 1994:314-326.
33. Wolbach SB. The etiology of Rocky Mountain spotted fever: a preliminary report. J Med Res 1916; 34:121-128.
34. Dawson JE, Candal FJ, George VG, et al. Human endothelial cells as an alternative to DH82 cells for isolation of Ehrlichia chaffeensis, E. canis, and Rickettsia rickettsii. Pathobiology 1993; 61:293-296.
35. Silverman DJ, Bond SB. Infection of human vascular endothelial cells by Rickettsia rickettsii. J Infect Dis 1984; 149:201-206.
36. Heinzen RA. Rickettsial actin-based motility: behavior and involvement of cytoskeletal regulators. Ann NY Acad Sci 2003; 990:535-547.
37. Heinzen RA, Grieshaber SS, Van Kirk LS, et al. Dynamics of actin-based movement by Rickettsia rickettsii in Vero cells. Infect Immun 1999; 67:4201-4207.
38. Policastro PF, Hackstadt T. Differential activity of Rickettsia rickettsii opmA and ompB promoter regions in a heterologous reporter gene system. Microbiology 1994; 140:2941-2949.
39. Buhles WC, Huxsoll DL, Ruch G, et al. Evaluation of primary blood monocyte and bone marrow cell culture for the isolation of Rickettsia rickettsii. Infect Immun 1975; 12:1457-1463.
40. Melles HB, Colombo S, Lemos ER. Isolamento de Rickettsia em cultura de células vero. Rev Soc Bras Med Trop 1999; 32:469-473.
41. Macaluso KR, Mulenga A, Simser JA, et al. Differential expression of genes in uninfected and Rickettsia-infected Dermacentor variabilis ticks as assessed by differential-display PCR. Infect Immun 2003; 71:6165-6170.
42. Li H, Walker DH. rOmpA is a critical protein for the adhesion of Rickettsia rickettsii to host cells. Microb Pathog 1998; 24:289-298.
43. Uchiyama T. Adherence to and invasion of Vero cells by recombinant Escherichia coli expressing the outer membrane protein rOmpB of Rickettsia japonica. Ann NY Acad Sci 2003; 990:585-590.
44. Silverman DJ, Santucci LA, Meyers N, et al. Penetration of host cells by Rickettsia rickettsii appears to be mediated by a phospholipase of rickettsial origin. Infect Immun 1992; 60:2733-2740.
45. Devamanoharan PS, Santucci LA, Hong JE, et al. Infection of human endothelial cells by Rickettsia rickettsii causes a significant reduction in the levels of key enzymes involved in protection against oxidative injury. Infect Immun 1994; 62:2619-2621.
46. Hong JE, Santucci LA, Tian X, et al. Superoxide dismutase-dependent, catalase-sensitive peroxides in human endothelial cells infected by Rickettsia rickettsii. Infect Immun 1998; 66:1293-1298.
47. Eremeeva ME, Dasch GA, Silverman DJ. Quantitative analyses of variations in the injury of endothelial cells elicited by 11 isolates of Rickettsia rickettsii. Clin Diagn Lab Immunol 2001; 8:788-796.
48. Rydkina E, Sahni A, Silverman DJ, et al. Rickettsia rickettsii infection of cultured human endothelial cells induces heme oxygenase 1 expression. Infect Immun 2002; 70:4045-4052.
49. Joshi SG, Francis CW, Silverman DJ, et al. Nuclear factor kappa B protects against host cell apoptosis during Rickettsia rickettsii infection by inhibiting activation of apical and effector caspases and maintaining mitochondrial integrity. Infect Immun 2003; 71:4127-4136.
50. Joshi SG, Francis CW, Silverman DJ, et al. NF-kappaB activation suppresses host cell apoptosis during Rickettsia rickettsii infection via regulatory effects on intracellular localization or levels of apoptogenic and anti-apoptotic proteins. FEMS Microbiol Lett 2004; 234:333-341.
51. Clifton DR, Goss RA, Sahni S, et al. NF-kappa B-dependent inhibition of apoptosis is essential for host cell survival during Rickettsia rickettsii infection. Proc Natl Acad Sci USA 1998; 95:4646-4651.
52. Clifton DR, Rydkina E, Freeman RS, et al. NF-kappaB activation during Rickettsia rickettsii infection of endothelial cells involves the activation of catalytic IkappaB kinases IKKalpha and IKKbeta and phosphorylation-proteolysis of the inhibitor protein IkappaBalpha. Infect Immun 2005; 73:155-165.
53. Heinzen RA, Hayes SF, Peacock MG, et al. Directional actin polymerization associated with spotted fever group rickettsia infection of Vero cells. Infect Immun 1993; 61:1926-1935.
54. Jeng RL, Goley ED, D’Alessio JA, et al. A Rickettsia WASP-like protein activates the Arp2/3 complex and mediates actin-based motility. Cell Microbiol 2004; 6:761-769.
55. Gouin E, Gantelet H, Egile C, et al. A comparative study of the actin-based motilities of the pathogenic bacteria Listeria monocytogenes, Shigella flexneri and Rickettsia conorii. J Cell Sci 1999; 112:1697-1708.
56. Gouin E, Welch MD, Cossart P. Actin-based motility of intracellular pathogens. Curr Opin Microbiol 2005; 8:35-45.
57. Gouin E, Egile C, Dehoux P, et al. The RickA protein of Rickettsia conorii activates the Arp2/3 complex. Nature 2004; 427:457-461.
58. Niebylski ML, Schrumpf ME, Burgdorfer W, et al. Rickettsia peacockii sp. nov., a new species infecting wood ticks, Dermacentor andersoni, in western Montana. Int J Syst Bacteriol 1997; 47:446-452.
59. Baldridge GD, Burkhardt NY, Simser JA, et al. Sequence and expression analysis of the ompA gene of Rickettsia peacockii, an endosymbiont of the Rocky Mountain wood tick, Dermacentor andersoni. Appl Environ Microbiol 2004; 70:6628-6636.
60. Hazard GW, Ganz RN, Nevin RW, et al. Rocky Mountain spotted fever in the eastern United States: thirteen cases from the Cape Cod area of Massachusetts. N Engl J Med 1969; 280:57-62.
61. Linnemann CC Jr, Janson PJ. The clinical presentations of Rocky Mountain spotted fever: comments on recognition and management based on a study of 63 patients. Clin Pediatr 1978; 17:673-679.
62. Helmick CG, Bernard KW, D’Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984; 150:480-488.
63. Kaplowitz LG, Fischer JJ, Sparling PF. Rocky Mountain spotted fever: a clinical dilemma. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases. New York: McGraw-Hill, 1981:89-107.
64. Ong HA, Raffeto JF. Rocky Mountain spotted fever: an analysis of eighteen cases in children. J Pediatr 1940; 40:647-653.
65. Centers for Disease Control and Prevention. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichiosis, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. Morb Mortal Wkly Rep 2006; 55(RR-4):1-29.
66. Harrell GT. Rocky Mountain spotted fever. Medicine (Baltimore) 1949; 28:333-370.
67. Sexton DJ, Burgdorfer W. Clinical and epidemiologic features of Rocky Mountain spotted fever in Mississippi, 1933-1973. Southern Med J 1975; 68:1529-1535.
68. Sexton DJ, Corey GR. Rocky Mountain “spotless” and “almost spotless” fever: a wolf in sheep’s clothing. Clin Infect Dis 1992; 15:439-448.
69. Hattwick MAW, O’Brien RJ, Hanson BF. Rocky Mountain spotted fever: epidemiology of an increasing problem. Ann Int Med 1976; 84:732-739.
70. Kirkland KB, Marcom PK, Sexton DJ, et al. Rocky Mountain spotted fever complicated by gangrene: report of six cases and review. Clin Infect Dis 1993; 16:629-634.
71. Elghetany MT, Walker DH. Hemostatic changes in Rocky Mountain spotted fever and Mediterranean spotted fever. Am J Clin Pathol 1999; 112:159-168.
72. Pincoffs MC, Guy EG, Lister LM, et al. The treatment of Rocky Mountain spotted fever with chloromycetin. Ann Intern Med 1948; 29:656-663.
73. Topping NH. Rocky Mountain spotted fever: a note on some aspects of its epidemiology. Public Health Rep 1941; 56:1699-1707.
74. Ross S, Schoenbach EB, Burke FG, et al. Aureomycin therapy of Rocky Mountain spotted fever. J Am Med Assoc 1948; 138:1213-1216.
75. Dalton MJ, Clarke MJ, Holman RC, et al. National surveillance for Rocky Mountain spotted fever, 1981-1992: epidemiologic summary and evaluation of risk factors for fatal outcome. Am J Trop Med Hyg 1995; 52:405-413.
76. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995; 20:1118-1121.
77. Paddock CD, Greer PW, Ferebee TL, et al. Hidden mortality attributable to Rocky Mountain spotted fever: immunohistochemical detection of fatal, serologically unconfirmed disease. J Infect Dis 1999; 179:1469-1476.
78. Eremeeva ME, Klemt RM, Santucci-Domotor LA, et al. Genetic analysis of isolates of Rickettsia rickettsii that differ in virulence. Ann NY Acad Sci 2003; 990:717-722.
79. Whelton A, Donadio JV, Elisberg BL. Acute renal failure complicating rickettsial infections in glucose-6-phosphate dehydrogenase-deficient individuals. Ann Int Med 1968; 69:323-328.
80. Walker DH, Hawkins HK, Hudson P. Fulminant Rocky Mountain spotted fever: its pathologic characteristics associated with glucose-6-phosphate dehydrogenase deficiency. Arch Pathol Lab Med 1983; 107:121-125.
81. Walker DH, Olano JP, Feng HM. Critical role of cytotoxic T lymphocytes in immune clearance of rickettsial infection. Infect Immun 2001; 69:1841-1846.
82. Valbuena G, Bradford W, Walker DH. Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol 2003; 163:1357-1369.
83. Parker RR. Rocky Mountain spotted fever. J Am Med Assoc 1938; 110:1273-1278.
84. DuPont HL, Hornick RB, Dawkins AT, et al. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii. J Infect Dis 1973; 128:340-344.
85. Parker RT, Menon PG, Merideth AM, et al. Persistence of Rickettsia rickettsii in a patient recovered from Rocky Mountain spotted fever. J Immunol 1954; 73:383-386.
86. Chapman AS, Murphy SM, Demma LJ, et al. Rocky Mountain spotted fever in the United States, 1997-2002. Vector Borne Zoonotic Dis. In press.
87. Bustamente ME, Varela G. Estudios de fiebre manchada en Mexico. Papel del Rhipicephalus sanguineus en la transmission de la fiebre manchada en la Republica Mexicana. Rev Inst Salub Enferm Trop 1947; 8:139-141.
88. McCalla LP. Direct transmission from man to man of the Rocky Mountain spotted (tick) fever. Med Sentinel 1908; 16:87-88.
89. Moore JJ. Time relationship of the wood-tick in the transmission of Rocky Mountain spotted fever. J Infect Dis 1911; 8:339-347.
90. Spencer RR, Parker RR. Rocky Mountain spotted fever: infectivity of fasting and recently fed ticks. Public Health Rep 1923; 38:333-339.
91. Wells GM, Woodward TE, Fiset P, et al. Rocky Mountain spotted fever caused by blood transfusion. J Am Med Assoc 1978; 239:2763-2765.
92. Spencer RR, Parker RR. Infection by means other than tick bites. Hyg Lab Bull 1930; 154:60-63.
93. Gordon JC, Gordon SW, Peterson E, et al. Epidemiology of Rocky Mountain spotted fever in Ohio, 1981: serologic evaluation of canines and rickettsial isolation from ticks associated with human case exposure sites. Am J Trop Med Hyg 1984; 33:1026-1031.
94. Treadwell TA, Holman RC, Clarke MJ, et al. Rocky Mountain spotted fever in the United States during 1993 through 1996. Am J Trop Med Hyg 2000; 63:21-26.
95. Clark KL, Oliver JH, McKechnie DB, et al. Distribution, abundance, and seasonal activities of ticks collected from rodents and vegetation in South Carolina. J Vector Ecol 1998; 23:89-105.
96. Eads RB, Smith GC. Seasonal activity and Colorado tick fever virus infection rates in Rocky Mountain wood ticks, Dermacentor andersoni (Acari: Ixodidae), in north-central Colorado, USA. J Med Entomol 1983; 20:49-55.
97. Lange JV, Walker DH, Wester TB. Documented Rocky Mountain spotted fever in wintertime. J Am Med Assoc 1982; 247:2403-2404.
98. de Lemos ER, Machado RD, Coura JR, et al. Epidemiological aspects of the Brazilian spotted fever: seasonal activity of ticks collected in an endemic area in Sao Paulo, Brazil. Rev Soc Bras Med Trop 1997; 30:181-185.
99. Childs JE, Paddock CD. Passive surveillance as an instrument to identify risk factors for fatal Rocky Mountain spotted fever: is there more to learn? Am J Trop Med Hyg 2002; 66:450-457.
100. Galvao MA, Dumler JS, Mafra CL, et al. Fatal spotted fever rickettsiosis, Minas Gerais, Brazil. Emerg Infect Dis 2003; 9:1402-1405.
101. Goncalves da Costa PS, Brigatte ME, Pereira DA, et al. Atypical fulminant Rickettsia rickettsii infection (Brazilian spotted fever) presenting as septic shock and adult respiratory distress syndrome. Braz J Infect Dis 2002; 6:91-96.
102. de Lemos ER, Rozental T, Villela CL. Brazilian spotted fever: description of a fatal clinical case in the State of Rio de Janeiro. Rev Soc Bras Med Trop 2002; 35:523-525.
103. Paddock CD, Sumner JW, Comer JA, et al. Rickettsia parkeri: a newly recognized cause of spotted fever rickettsiosis in the United States. Clin Infect Dis 2004; 38:805-811.
104. Jones TF, Craig AS, Paddock CD, et al. Family cluster of Rocky Mountain spotted fever. Clin Infect Dis 1999; 28:853-859.
105. Sanchez JL, Candler WH, Fishbein DB, et al. A cluster of tick-borne infections-association with military training and asymptomatic infections due to Rickettsia rickettsii. Trans R Soc Trop Med Hyg 1992; 86:321-325.
106. McCall CL, Curns AT, Singleton JS, et al. Fort Chaffee revisited: the epidemiology of tickborne diseases at a persistent focus. Vector Borne Zoonotic Dis 2001; 2:119-127.
107. Centers for Disease Control and Prevention. Fatal cases of Rocky Mountain spotted fever in family clusters-three states, 2003. Morb Mortal Wkly Rep 2004; 53:407-410.
108. Massachusetts Department of Health. On the alert for Rocky Mountain spotted fever. N Engl J Med 1975; 292:1127-1129.
109. Topping NH. The epidemiology of Rocky Mountain spotted fever. NY State J Med 1947; 47: 1585-1587.
110. Sexton DJ, Burgdorfer W, Thomas L, et al. Rocky Mountain spotted fever in Mississippi: survey for spotted fever antibodies in dogs and for spotted fever group rickettsiae in dog ticks. Am J Epidemiol 1976; 103:192-197.
111. Steinfeld HJ, Silverstein J, Weisburger W, et al. Deafness associated with Rocky Mountain spotted fever. Md Med J 1988; 37:287-288.
112. Elchos BN, Goddard J. Implications of presumptive fatal Rocky Mountain spotted fever in two dogs and their owner. J Am Vet Med Assoc 2003; 223:1450-1452.
113. Paddock CD, Brenner O, Vaid C, et al. Concurrent Rocky Mountain spotted fever in a dog and its owner. Am J Trop Med Hyg 2002; 66:197-199.
114. Pretzman C, Daugherty N, Poetter K, et al. The distribution and dynamics of Rickettsia in the tick population of Ohio. Ann NY Acad Sci 1990; 590:227-236.
115. Horta MC. Pesquisa de infecção por riquétsias do grupo da febre maculosa em humanos, caninos e em diferentes estádios de vida de Amblyomma cajennese, provenientes de uma área endêmica do estado de São Paulo, Brasil. Thesis Dissertation, Universidade de São Paulo, 2002.
116. Gage KL, Schrumpf ME, Karstens RH, et al. DNA typing of rickettsiae in naturally infected ticks using a polymerase chain reaction/restriction fragment length polymorphism system. Am J Trop Med Hyg 1994; 50:247-260.
117. Burgdorfer W, Hayes SF, Mavros AJ. Nonpathogenic rickettsiae in Dermacentor andersoni: a limiting factor for the distribution of Rickettsia rickettsii. In: Burgdorfer W, Anacker RL, eds. Rickettsiae and Rickettsial Diseases. New York: Academic Press, 1981:585-594.
118. Philip CB. Some epidemiological considerations in Rocky Mountain spotted fever. Public Health Rep 1959; 74:595-600.
119. Rollin PE, Ksiazek TG. Ebola haemorrhagic fever. Trans R Soc Trop Med Hyg 1998; 92:1-2.
120. Paddock CD, Holman RC, Krebs JW, et al. Assessing the magnitude of fatal Rocky Mountain spotted fever in the United States: comparison of two national data sources. Am J Trop Med Hyg 2002; 67:349-354.
121. Fishbein DB, Frontini MG, Giles R, et al. Fatal cases of Rocky Mountain spotted fever in the United States, 1981-1988. Ann NY Acad Sci 1990; 590:246-247.
122. Holman RC, Paddock CD, Curns AT, et al. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J Infect Dis 2001; 184:1437-1444.
123. Zavala-Velazquez JE, Yu XJ, Walker DH. Unrecognized spotted fever group rickettsiosis masquerading as dengue fever in Mexico. Am J Trop Med Hyg 1996; 55:157-159.
124. Lowenstein R. Deadly viral syndrome mimics. Emerg Med Clin North Am 2004; 22:1051-1065.
125. Masters EJ, Olson GS, Weiner SJ, et al. Rocky Mountain spotted fever: a clinician’s dilemma. Arch Intern Med 2003; 163:769-774.
126. Zaki MH. Selected tickborne infections-a review of Lyme disease, Rocky Mountain spotted fever, and babesiosis. NY State J Med 1989; 6:320-335.
127. Schreck CE, Snoddy EL, Spielman A. Pressurized sprays of permethrin or DEET on military clothing for personal protection against Ixodes dammini (Acari: Ixodidae). J Med Entomol 1988; 23:396-399.
128. O’Reilly M, Paddock C, Elchos B, et al. Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002. Ann NY Acad Sci 2003; 990:295-301.
129. Woodward TE. Rocky Mountain spotted fever: epidemiological and early clinical signs are keys to treatment and reduced mortality. J Infect Dis 1984; 150:465-468.
130. Tzianabos T, Anderson BE, McDade JE. Detection of Rickettsia rickettsii DNA in clinical specimens by using polymerase chain reaction technology. J Clin Microbiol 1989; 27:2866-2868.
131. Centers for Disease Control and Prevention, National Institutes of Health. Biosafety in Microbiological and Biomedical Laboratories. Washington, DC: U.S. Government Printing Office, 1999.
132. Wolf GL, Cole CR, Carlisle HN, et al. The pathogenesis of Rocky Mountain spotted fever in monkeys, infected by inhalation. Arch Pathol 1967; 84:486-494.
133. Oster CN, Burke DS, Kenyon RH, et al. Laboratory-acquired Rocky Mountain spotted fever. N Engl J Med 1977; 297:859-863.
134. Johnson JE, Kadull PJ. Rocky Mountain spotted fever acquired in a laboratory. N Engl J Med 1967; 277:842-847.
135. Parker RR. Rocky Mountain spotted fever: results of fifteen years’ prophylactic vaccination. Am J Trop Med 1941; 21:369-383.
136. Harden VA. Rocky Mountain Spotted Fever: History of a 20th Century Disease. Baltimore: The Johns Hopkins University Press, 1990, with Centers for Disease Control and Prevention. Fatal rocky mountain spotted fever-Georgia. Morb Mortal Wkly Rep 1977; 28:84.
137. Raoult D, Paddock CD. Rickettsia parkeri infection and other spotted fevers in the United States. N Engl J Med 2005; 353:626-627.
138. Paddock CD. Rickettsia parkeri as a paradigm for multiple cause of tickborne spotted fever in the Western Hemisphere. Ann NY Acad Sci 2005; 1063:315-326.
139. Parola P, Paddock CD, Raoult D. Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 2005; 18:719-756.
140. Eremeeva ME, Bosserman EA, Demma LJ, Zambrand ML, Blau DM, Dasch GA. Isolation and identification of Rickettsia massiliae in Rhipicephalus sanguineus ticks from Arizona. Appl Environ Microbiol 2006; 72:5569-5577.
141. McDade JE. Diagnosis of rickettsial diseases: a perspective. Eur J Epidemiol 1991; 7:270-275.
142. Ripoll CM, Remondegui CE, Ordonez G, et al. Evidence of spotted fever and ehrlichial infections in a subtropical territory of Jujuy, Argentina. Am J Trop Med Hyg 1999; 61:350-354.
143. Schoeler GB, Moron C, Richards A, et al. Human spotted fever rickettsial infections. Emerg Infect Dis 2005; 11:622-624.
144. de Lemos ERS, Alvarenga FBF, Cintra ML, et al. Spotted fever in Brazil: a seroepidemiologic study and description of clinical cases in an endemic area in the state of São Paulo. Am J Trop Med Hyg 2001; 65:329-334.
145. Zavala-Castro JE, Zavala-Velázquez JE, Walker DH, et al. Fatal human infection with Rickettsia rickettsii, Yucatán, Mexico. Emerg Infect Dis 2006; 12:672-674.
146. Valbuena G, Olano J, Bouyer D, Walker D. Rocky mountain spotted fever in Colombia: a forgotten disease strikes again. Fourth international conference on Rickettsiae and Rickettsial Diseases [abstract P-168]. Spain: Logrono (La Rioja), 2005.
147. Centers for Disease Control and Prevention. Consequences of delayed diagnosis of Rocky Mountain spotted fever in children-West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000. Morb Mortal Wkly Rep 2000; 49:885-888.
148. Walker DH. Rickettsia rickettsii: as virulent as ever. Am J Trop Med Hyg 2002; 66:448-449.
149. Woodward TE. A historical account of the rickettsial diseases with a discussion of unsolved problems. J Infect Dis 1973; 127:583-594.